ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ELEV Elevation Oncology Inc

3.84
0.15 (4.07%)
2024年5月25日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Elevation Oncology Inc ELEV NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.15 4.07% 3.84 05:12:47
始値 安値 高値 終値 前日終値
3.66 3.565 4.15 3.84 3.69
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/1805:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/5/1013:15EDGAR2Form EFFECT - Notice of Effectiveness
2024/5/1005:39EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
2024/5/0720:30PRNUSElevation Oncology to Present at the Citizens JMP Life..
2024/5/0220:30PRNUSElevation Oncology Reports First Quarter 2024 Financial..
2024/4/0905:30PRNUSElevation Oncology Presents Preclinical Proof-of-Concept..
2024/3/0622:14EDGAR2Form S-8 - Securities to be offered to employees in employee..
2024/3/0621:45EDGAR2Form 8-K - Current report
2024/3/0621:30PRNUSElevation Oncology Reports Fourth Quarter and Full Year 2023..
2024/3/0621:00EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
2024/3/0606:50PRNUSElevation Oncology to Present Preclinical Proof-of-Concept..
2024/3/0506:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/3/0506:21EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/3/0421:30PRNUSElevation Oncology Appoints Experienced Clinical Development..
2024/2/2821:30PRNUSElevation Oncology to Participate in Upcoming Investor..
2024/2/2221:30PRNUSElevation Oncology Expands Ongoing Phase 1 Clinical Trial of..
2024/2/2107:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2106:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/1506:45EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/2406:15EDGAR2Form 8-K - Current report
2024/1/2306:57EDGAR2Form SC 13G - Statement of acquisition of beneficial..
2024/1/2306:35EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/2306:24EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/1/2221:45EDGAR2Form 8-K - Current report
2024/1/2221:30PRNUSElevation Oncology Announces Appointment of Darcy Mootz,..
2024/1/1006:24EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/1/0521:40EDGAR2Form 8-K - Current report
2024/1/0521:30PRNUSElevation Oncology Announces Program Updates and Upcoming..
2023/11/2221:30PRNUSElevation Oncology to Present at the Piper Sandler 35th..
2023/11/0220:45EDGAR2Form 8-K - Current report
2023/11/0220:30PRNUSElevation Oncology Reports Third Quarter 2023 Financial..
2023/11/0220:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/9/2305:30EDGAR2Form 8-K - Current report
2023/9/0520:30PRNUSElevation Oncology to Present at the H.C. Wainwright 25th..
2023/8/1620:45EDGAR2Form 8-K - Current report
2023/8/1620:30PRNUSElevation Oncology Announces First Patient Dosed in the..
2023/8/0320:45EDGAR2Form 8-K - Current report
2023/8/0320:30PRNUSElevation Oncology Reports Second Quarter 2023 Financial..
2023/8/0320:15EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
2023/8/0320:01EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/7/1505:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2023/7/1505:26EDGAR2Form 3 - Initial statement of beneficial ownership of..
2023/7/1321:15EDGAR2Form 8-K - Current report
2023/7/1321:00PRNUSElevation Oncology Appoints Joseph Ferra as Chief Executive..
2023/6/0911:41PRNUSElevation Oncology Announces Pricing of $50 Million Public..
2023/6/0905:01PRNUSElevation Oncology Announces Launch of Proposed Public..
2023/6/0322:00PRNUSElevation Oncology Highlights First-in-Human Phase 1..

最近閲覧した銘柄

Delayed Upgrade Clock